Cardiac Implants Market: Growth Accelerated by Technological Advancements

Cardiac Implants Market


Cardiac implants are medical devices that are surgically implanted in the heart to diagnose, treat or manage various heart diseases and disorders. Cardiac pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization therapy devices are some key cardiac implants used widely. Cardiac implants have significantly improved the treatment of various heart conditions and helped save many lives. The global Cardiac Implants Market is estimated to be valued at US$ 35,795.6 Mn in 2023 and is expected to exhibit a CAGR of 8.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:

Technological advancements have accelerated the growth of the cardiac implants market. Manufacturers are developing miniaturized and advanced implantable devices to serve the growing needs of patients. Wireless cardiac implants with Bluetooth and smartphone connectivity are gaining traction as they allow remote monitoring of implanted devices and patients' health status from anywhere. Miniaturized implants with longer battery life and enhanced functionalities are improving patient comfort and clinical outcomes. Further, the rise of artificial intelligence and nanotechnology is spurring innovations in cardiac implants. New materials and designs are allowing implants to seamlessly integrate with the body with minimal rejections. These technological upgrades are expanding the market reach and driving revenues in the cardiac implants industry.

Segment Analysis
The global cardiac implants market is segmented by product into pacemakers, defibrillators, cardiac resynchronization therapy (CRT), prosthetic heart valves, stents, implantable cardioverter defibrillator (ICD). Among these, the pacemakers segment dominates the market with around 30% share in 2023. Pacemakers help regulate abnormal heart rhythms by sending electrical pulses to stimulate the heart. Pacemakers are commonly used for treating bradycardia, a condition characterized by abnormally slow heart rhythms. They have widespread applications and acceptance in the medical community.

Key Takeaways

Global Cardiac Implants Market Demand is expected to witness high growth.

Regional analysis: The North America region currently dominates the global market with over 40% value share in 2023. Presence of highly developed hospitals and healthcare infrastructure, rising medical expenditures, growing geriatric population at risk of developing cardiovascular diseases are some key factors driving the North American market. However, the Asia Pacific region is expected to grow at the fastest pace during the forecast period. Growing medical tourism industry, improving healthcare infrastructure, rising incidence of cardiovascular diseases due to rapidly changing lifestyle in developing economies are fueling the demand for cardiac implants in Asia Pacific.

Key players operating in the cardiac implants market are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Pvt. Ltd., Lepu Medical Technology (Beijing) Co., Ltd., BIOTRONIK SE & Co. KG, OSYPKA MEDICAL, Pacetronix.com, Vitatron, Terumo Corporation, Cordis, MicroPort Scientific Corporation. Boston Scientific and Medtronic currently occupy over 50% market share. Major players are focusing on developing technologically advanced products and increasing their geographic presence through strategic mergers and acquisitions to strengthen their market position.


Comments

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

The Global Methyl & Ethyl Chloroacetate Market Is Expected To Register A Cagr Of 7.9% In Terms Of Revenue Over The Forecast Period (2019-2027)